The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA

被引:41
作者
Kooij, Loes [1 ]
Tymstra, Tjeerd [1 ]
van den Berg, Paul [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, NL-9713 AV Groningen, Netherlands
关键词
noninvasive prenatal diagnosis; Down syndrome; fetal DNA; maternal blood; opinion; PRENATAL-DIAGNOSIS; PLASMA; SERUM;
D O I
10.1002/pd.2205
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective To determine the opinions of women about the new developments in the field of noninvasive prenatal diagnosis (NIPD). Method Prospective study using questionnaires in two groups of women: women visiting the University Medical Centre Groningen and the Martini Hospital Groningen for the routine fetal anomaly ultrasound scan at 20 weeks' gestation and female medical master students. Results Both groups consider NIPD an important asset in the reliable diagnosis of fetal aneuploidy and gender-determined genetic disorders, with the exception of disorders manifesting themselves later in life. There is a negative response as to its application for family balancing. Eighty-two percent of the pregnant women and 79% of the medical students responded positively to the question whether they consider NIPD an important asset in prenatal care. The statement that it is an asset because it enables pregnant women to bear an 'optimal child' is strongly rejected by both groups. Conclusions NIPD paves the way for screening on a large scale. Our survey shows that women feel positive about these new possibilities, but find it hard to fully realize the consequences and new choices they will be confronted with. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 10 条
[1]  
Amicucci P, 2000, CLIN CHEM, V46, P301
[2]   A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study [J].
Dhallan, Ravinder ;
Guo, Xin ;
Emche, Sarah ;
Damewood, Marian ;
Bayliss, Philip ;
Cronin, Michael ;
Barry, Julie ;
Betz, Jordan ;
Franz, Kara ;
Gold, Katie ;
Vallecillo, Brett ;
Varney, John .
LANCET, 2007, 369 (9560) :474-481
[3]   Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR [J].
González-González, MC ;
Trujillo, MJ ;
de Alba, MR ;
García-Hoyos, M ;
Lorda-Sánchez, I ;
Díaz-Recasens, J ;
Ayuso, C ;
Ramos, C .
PRENATAL DIAGNOSIS, 2003, 23 (03) :232-234
[4]   Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma [J].
González-González, MC ;
García-Hoyos, M ;
Trujillo, MJ ;
de Alba, MR ;
Lorda-Sánchez, I ;
Díaz-Recasens, J ;
Gallardo, E ;
Ayuso, C ;
Ramos, C .
PRENATAL DIAGNOSIS, 2002, 22 (10) :946-948
[5]   Women's opinion on the use and offer of ovarian reserve testing: A First step towards a wide ranged social discussion [J].
Kooij, L ;
Bukman, A ;
Hoek, A ;
Heineman, MJ ;
Tymstra, TJ .
JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 2005, 26 (03) :205-209
[6]   Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection [J].
Lo, Y. M. Dennis ;
Tsui, Nancy B. Y. ;
Chiu, Rossa W. K. ;
Lau, Tze K. ;
Leung, Tse N. ;
Heung, Macy M. S. ;
Gerovassili, Ageliki ;
Jin, Yongjie ;
Nicolaides, Kypros H. ;
Cantor, Charles R. ;
Ding, Chunming .
NATURE MEDICINE, 2007, 13 (02) :218-223
[7]   Presence of fetal DNA in maternal plasma and serum [J].
Lo, YMD ;
Corbetta, N ;
Chamberlain, PF ;
Rai, V ;
Sargent, IL ;
Redman, CWG ;
Wainscoat, JS .
LANCET, 1997, 350 (9076) :485-487
[8]   Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience [J].
Spencer, K ;
Spencer, CE ;
Power, M ;
Dawson, C ;
Nicolaides, KH .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (03) :281-286
[9]  
Weinans MJN, 2000, PRENATAL DIAG, V20, P705, DOI 10.1002/1097-0223(200009)20:9<705::AID-PD904>3.0.CO
[10]  
2-C